Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kumar, A.
Right arrow Articles by Garg, O. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, A.
Right arrow Articles by Garg, O. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 37, 331-333, Copyright © 1998 by British Society for Rheumatology

ORIGINAL PAPERS

Relapse of Wegener's granulomatosis in the first trimester of pregnancy: a case report

A Kumar, A Mohan, R Gupta, VK Singal and OP Garg
Clinical Immunology Service, Department of Medicine, All India Institute of Medical Sciences, New Delhi.

The association of Wegener's granulomatosis and pregnancy is rare and poses unique therapeutic challenges, particularly when active disease presents in early pregnancy. We describe a 22-yr-old woman who recovered successfully from her initial episode of Wegener's granulomatosis with a standard course of treatment with prednisolone and cyclophosphamide. Two and a half years later, she presented with relapse during the first trimester of pregnancy (primigravida). Since the clinical features suggested mild disease, she was started on prednisolone at a dose of 1 mg/kg/day, to which she seemed to respond very well for 3 months. Unfortunately, she had a spontaneous abortion at 5 months of gestation while on 25 mg/day of prednisolone. At this time, her disease flared further, with clinically manifest lung disease which was not part of her initial presentation. She was treated with another course of oral cyclophosphamide and prednisolone, and a remission was achieved in 4 months. There are no agreed guidelines on the treatment of Wegener's granulomatosis during pregnancy. In this report, the therapeutic issues are discussed against the background of the available literature.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
A. Scholz, K. Srinivas, M. R. W. Stacey, and P. Clyburn
Subglottic stenosis in pregnancy
Br. J. Anaesth., March 1, 2008; 100(3): 385 - 388.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. B. Piccoli, E. Mezza, S. Bontempo, M. Burdese, G. Soragna, M. Gai, V. Consiglio, A. Jeantet, G. P. Segoloni, G. Piccoli, et al.
Vasculitis and kidney involvement in pregnancy: evidence-based medicine and ethics bear upon clinical choices
Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2909 - 2913.
[Full Text] [PDF]

Home page
 Ann Rheum DisHome page
C. Auzary, D. l. T. Huong, B. Wechsler, D. Vauthier-Brouzes, and J.-C. Piette
Pregnancy in patients with Wegener's granulomatosis: report of five cases in three women
Ann Rheum Dis, October 1, 2000; 59(10): 800 - 804.
[Abstract] [Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.